@article{588b8fa5a5174cd8a38e57366bd498ae,
title = "“The role of case management in HIV treatment adherence: HPTN 078”",
abstract = "Adherence to care and antiretroviral therapy is challenging, especially for people living with HIV (PLWH) with additional co-occurring risk factors. Case management interventions, including motivational interviewing (MI), show promise to improve HIV treatment adherence, but few studies have examined how such interventions are delivered to or experienced by PLWH who have been reengaged in care. We conducted qualitative interviews with six case managers and 110 PLWH exiting from a randomized study (HPTN 078) who received a MI-based case management intervention in addition to standard patient-navigation services, or standard services only. Our study provided greater insight into the main findings from HPTN 078, including an in-depth description of the multiple barriers to adherence faced by this largely “out-of-care” population, as well as a more nuanced understanding of the benefits and challenges of implementing MI. A blend of MI plus more intensive interventions may be needed for PLWH facing multiple structural barriers.",
keywords = "Adherence, Case management, HIV treatment, Motivational interviewing",
author = "Tolley, {Elizabeth E.} and Hamilton, {Erica L.} and Natalie Eley and Maragh-Bass, {Allysha C.} and Eunice Okumu and Bal{\'a}n, {Iv{\'a}n C.} and Theresa Gamble and Chris Beyrer and Robert Remien",
note = "Funding Information: We would like to sincerely thank the primary study team, case managers and study participants. We would also like to thank the efforts of Mr. Christopher Hucks-Ortiz, Mr. Craig Hutchinson, Ms. Anna Lawton and Ms. Jamilah Taylor for their contributions to data collection of the exit interviews, as well as preliminary data analysis of the qualitative data. Overall support for the HIV Prevention Trials Network (HPTN) is provided by the National Institute of Allergy and Infectious Diseases (NIAID), Office of the Director (OD), National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH) under Award Numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. Funding Information: Overall support for this study was provided by the National Institute of Allergy and Infectious Diseases (NIAID), Office of the Director (OD), National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH) under Award Numbers UM1AI068619 (HPTN Leadership and Operations Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068613 (HPTN Laboratory Center). Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2022",
month = sep,
doi = "10.1007/s10461-022-03644-2",
language = "English (US)",
volume = "26",
pages = "3119--3130",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "9",
}